news & events
ysios news
20.04.21
Synendos Therapeutics Expands Series A to CHF 24 million with new investment
25.03.21
LAVA Therapeutics Announces Pricing of Initial Public Offering
22.03.21
Aura Biosciences Announces Oversubscribed $80 Million Financing
06.01.21
CorWave Raises €35 Million in Series C Funding for Its Breakthrough Heart Pump; EIC Fund Joins as New Investor
12.11.20
Galecto Announces Pricing of Initial Public Offering
21.10.20
SparingVision Raises €44.5 Million and Appoints Stéphane Boissel as Chief Executive Officer
28.09.20
Galecto Raises $64 Million to Accelerate Development of Clinical Pipeline
18.09.20
LAVA Therapeutics Announces $83 million Series C Financing to Advance Novel Immuno-Oncology Programs
15.09.20
ProteoDesign announces new Investment led by Ysios Capital and rebrands as Splice Bio
08.07.20
VarmX raises €32 million in Series B financing to develop innovative reversal agent for the treatment and prevention of severe bleeding in patients on oral anticoagulants
